文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

呼吸ICU 16年间结核所致急性呼吸窘迫综合征

Acute Respiratory Distress Syndrome Due To Tuberculosis in a Respiratory ICU Over a 16-Year Period.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论结核相关ARDS在呼吸ICU 16年收治的469例ARDS中仅18例,其ICU病死率与其他病因ARDS无差异(27.7% vs 28.2%,p=0.71)。

该研究为印度北部三级医院呼吸ICU 16年回顾性分析,连续纳入469例ARDS患者,分为结核相关ARDS组(18例)与其他病因ARDS组(451例),均按ARDS Network方案采用低潮气量策略机械通气。两组基线特征与肺力学相似;总死亡132例(28.1%),结核相关ARDS与其他病因ARDS病死率无差异(27.7% vs 28.2%,p=0.71),无呼吸机天数、ICU及住院时间亦无显著差异。多因素logistic回归显示,校正PaO2:FIO2比值、性别及ARDS病因后,预测生存的因素为入ICU时APACHE II评分与基线驱动压。结论认为结核是ARDS的不常见病因,结核相关ARDS表现与其他病因ARDS相似,不影响ICU生存。

要点

  • 在呼吸ICU 16年收治的469例ARDS中,结核相关ARDS为18例,其他病因ARDS为451例。
  • 结核相关ARDS与其他病因ARDS的ICU病死率无差异:27.7% vs 28.2%(p=0.71),总死亡132例(28.1%)。
  • 两组无呼吸机天数、ICU住院时间及住院时间均无显著差异。
  • 多因素logistic回归显示,校正PaO2:FIO2比值、性别及ARDS病因后,预测生存的因素为入ICU时APACHE II评分与基线驱动压。
  • 作者结论认为,结核是ARDS的不常见病因,结核相关ARDS表现与其他病因ARDS相似,不影响ICU生存。

适用人群与场景

  • 连续纳入印度北部三级医院呼吸ICU 16年间收治的ARDS患者,共469例(结核相关ARDS 18例,其他病因ARDS 451例)。
  • 研究人群平均(SD)年龄33.6岁(14.8年),女性占52.9%。

处置流程与药物剂量

  • 所有患者均按ARDS Network方案采用低潮气量策略进行机械通气。

研究设计与关键结果

  • 研究类型为回顾性分析,纳入呼吸ICU 16年间连续收治的ARDS患者469例(结核相关ARDS 18例,其他病因ARDS 451例)。
  • 两组基线临床与人口学特征及肺力学相似。
  • 总死亡132例(28.1%);结核相关ARDS与其他病因ARDS病死率无差异(27.7% vs 28.2%,p=0.71)。
  • 两组无呼吸机天数、ICU住院时间及住院时间无显著差异。
  • 多因素logistic回归显示,校正PaO2:FIO2比值、性别及ARDS病因后,预测生存的因素为入ICU时APACHE II评分与基线驱动压。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,结核是ARDS的不常见病因,即使在高结核患病率国家亦然;结核相关ARDS表现与其他病因ARDS相似,不影响ICU生存。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Whether tuberculosis-related acute respiratory distress syndrome is associated with worse outcomes when compared with acute respiratory distress syndrome secondary to other causes remains unknown. Herein, we compare the outcomes between the two groups.

DESIGN: Retrospective analysis of all subjects admitted with acute respiratory distress syndrome over the last 16 years.

SETTING: Respiratory ICU of a tertiary care hospital in North India.

SUBJECTS: Consecutive subjects with acute respiratory distress syndrome.

INTERVENTION: Subjects were categorized as tuberculosis-related acute respiratory distress syndrome and acute respiratory distress syndrome-others and were managed with mechanical ventilation using the low tidal volume strategy as per the Acute Respiratory Distress Syndrom Network protocol.

MEASUREMENTS AND MAIN RESULTS: The baseline clinical and demographic characteristics, lung mechanics, and mortality were compared between the two groups. Factors predicting ICU survival were analyzed using multivariate logistic regression analysis. During the study period, 469 patients (18 tuberculosis-related acute respiratory distress syndrome and 451 acute respiratory distress syndrome-others) with acute respiratory distress syndrome were admitted. The mean (SD) age of the study population (52.9% women) was 33.6 years (14.8 yr). The baseline parameters and the lung mechanics were similar between the two groups. There were 132 deaths (28.1%) with no difference between the two groups (tuberculosis-related acute respiratory distress syndrome vs acute respiratory distress syndrome-others; 27.7% vs 28.2%; p = 0.71). There was also no significant difference in the ventilator-free days, ICU, and the hospital length of stay. On multivariate logistic regression analysis, the factors predicting survival were the admission Acute Physiology and Chronic Health Evaluation II score and baseline driving pressure after adjusting for PaO2:FIO2 ratio, gender, and the etiology of acute respiratory distress syndrome.

CONCLUSIONS: Tuberculosis is an uncommon cause of acute respiratory distress syndrome even in high tuberculosis prevalence countries. Acute respiratory distress syndrome due to tuberculosis behaves like acute respiratory distress syndrome due to other causes and does not affect the ICU survival.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Muthu V, Dhooria S, Aggarwal AN, et al. Acute Respiratory Distress Syndrome Due To Tuberculosis in a Respiratory ICU Over a 16-Year Period. Crit Care Med. 2017. PMID: 28441233. doi:10.1097/CCM.0000000000002479

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。